we have just drifted down from $0.80-0.90 on almost no volume. In my opinion, this is as a significant buying opportunity. L&S: remember Iomai drifted down to $0.72 before the buyout at $6.60. It seemed like management didn't care, but all the while, they were working behind the scenes on a lot of deals that eventually boosted the stock price and led to the buyout.
I think at some point we just have to trust these guys. They seem to be incredibly smart and I'm sure they're doing whatever is necessary to ensure ZIOP is ultimately a success.
$5.15 though...that is tough. I would load up at $0.50 if I were you...
I know. The problem is as the cash burns their bargaining position weakens. I continue to question if ZIOP needs its current headcount. I think the science side has progressed(remember they have 3 programs) but the business side has been a total washout.
ZIOP acquired ZIO-101 (organic arsenic drug) 4 1/2 years ago. It is hard to believe that nobody has expressed an interest in partnering that compound based on its better tox profile etc. I just don't get it.